Davide Leone & Partners Investment CO Ltd. Biogen Inc. Transaction History

Davide Leone & Partners Investment CO Ltd.

  • $0
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$220.06 - $304.07 $30.6 Million - $42.3 Million
-139,107 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$217.44 - $243.88 $30.2 Million - $33.9 Million
139,107 New
139,107 $32.4 Million

Others Institutions Holding BIIB

# of Institutions
1,028
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Davide Leone & Partners Investment CO Ltd. Portfolio

Follow Davide Leone & Partners Investment CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email